Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Organisation › Details

Inovio Pharmaceuticals Inc. (Nasdaq: INO)

Inovio is revolutionizing the fight against cancer and infectious diseases. Our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favourable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, Roche, University of Pennsylvania, DARPA, GeneOne Life Science, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and University of Manitoba. *


Period Start 2010-05-01 renamed date ca
  Group Inovio (Group)
  Predecessor Inovio Biomedical Corporation (AMEX: INO)
Products Industry electroporation technology
  Industry 2 DNA vaccine
Person Person Kim, J. Joseph (Inovio 200906 CEO before VGX Pharmaceuticals 200807 CEO + co-founder)
  Street 1787 Sentry Parkway West
Building 18, Suite 400
  City 19422 Blue Bell, PA
  Tel +1-267-440-4200
    Address record changed: 2018-07-24
Basic data Employees n. a.
  Currency USD
  Annual sales 4,800,000 (revenue, total, consolidated (2007) 2007-12-31)
  Profit -11,200,000 (2007-12-31)
  Cash 10,250,929 (2007-12-31)
    * Document for �About Section�: AstraZeneca plc. (8/10/15). "Press Release: MedImmune Enters into Strategic Cancer Vaccine Collaboration and License Agreement with Inovio Pharmaceuticals".
Record changed: 2019-05-20


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Inovio (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top